A B S T R A C T Obese-hyperglycemic (ob/ob) mice have the interesting feature of being hyperinsulinemic, thus having some characteristics in common with human maturity-onset diabetics. As the cause of hyperinsulinemia in these mice is not established, and as the liver is known to play a role in determining the amount of hormone that reaches the periphery, it was hypothesized that an anomaly in the hepatic handling of insulin might prevail in obese-hyperglycemic mice. Immunoreactive insulin was therefore measured in the perfusate before and after a single passage through perfused livers of lean and ob/ob mice, permitting the calculation of insulin removal. It was found that the removal of insulin by livers of lean mice increased with increasing concentrations of the hormone in the portal vein. The removal process had a limited capacity, however, and as a consequence the percentage of hormone removed by the liver actually decreased when portal insulin concentrations increased. Insulin removal by livers of ob/ob mice had qualitatively the same characteristics but was considerably less efficient than in normal livers. Due to this, more insulin was found in the perfusate leaving the liver of ob/ob mice than in that of controls, at any insulin concentration tested. These observations suggest that in obese-hyperglycemic mice more of the hormone may reach the periphery and thus contribute to hyperinsulinemia. The present study further suggests that the anomaly of insulin removal observed in perfused livers of ob/ob mice might be secondary to hyperinsulinemia, since it was partly corrected upon artificially decreasing the circulating levels of insulin (e.g. via a fast, anti-
INTRODUCTION
The liver has been shown to be important in determining the amount of insulin reaching the peripheral blood. Several in vivo investigations carried out in man and dog indicate that this organ removes significant quantities of insulin (1) (2) (3) (4) . This has been further substantiated in the rat by measurement of insulin removal in vitro by liver perfusion techniques (5) (6) (7) (8) (9) . Such in vitro studies have suggested that the insulin removal was greater when less insulin reached the liver (10, 11) .
Moreover, when circulating insulin levels of normal rats were decreased by fasting or streptozotocin treatment, the removal of insulin by subsequently isolated livers was greater than in livers obtained from fed normal controls (10, 11) , and was restored towards values observed in control livers by feeding or by administration of insulin, respectively (11) .
Hyperinsulinemia is one of the main feature of the syndrome of the obese-hyperglycemic (ob/ob) mice (12) , and it appears to be of prime importance for the development of obesity in these animals (13, 14) . It was therefore hypothesized that livers of the ob/ob mice might be abnormal in their handling of insulin, and that such an anomaly might contribute to peripheral hyperinsulinemia.
METHODS
Animals. 8 or 1l-wk-old male obese-hyperglycemic (C57 BL/6J ob/ob) mice purchased from the Jackson Laboratories, Bar Harbor, Me., and lean control (C57BL/6J ++/++)
The Journal of Clinical Investigation Volume 57 May 1976 1117-1124 mice, bred in these laboratories, were used throughout these studies. Obese-hyperglycemic mice were made insulindeficient by intraperitoneal injection (after a 24-h fast) of 200 mg/kg streptozotocin diluted in 0.9% NaCl, acidified (pH 4) with 0.05 M citric acid, or by the administration of anti-insulin serum (AIS) ' (0.1 ml, neutralizing capacity of 2.16 U/ml) injected into a tail vein 2 h before the experiment. Lean mice were made insulin deficient by AIS injection only (0.05 ml i.v.). All animals were fed ad libitum with laboratory chow or fasted for various durations as specified for each different experiment.
Perfusion technique. Mice were anesthetized by intraperitoneal injection of pentobarbital (100 mg/kg). Samples of blood were taken from the retro-orbital sinus for measurements of plasma glucose and insulin levels, and livers were subsequently perfused in situ by the method of Assimacopoulos-Jeannet et al. (15) .
The perfusion medium was a Krebs-Ringer bicarbonate buffer, containing 3% bovine serum albumin, defatted with charcoal by the method of Chen (16) , and 20% washed bovine erythrocytes. The perfusion medium was not recirculated, all experiments being thus carried out with the so-called "flow-through" technique. After a preperfusion period of 15 min, porcine insulin diluted in NaCl 0.9% containing 1%yo human serum albumin was infused at constant rate into the medium entering the liver. The perfusate leaving the liver was collected every 3 min in a fraction collector.
Measurements. Immunoreactive insulin was determined in the perfusate before and after a single passage through the liver by the method of Herbert et al. (17) , with antipork insulin antibody and pork insulin standards. For the measurement of plasma insulin levels, mouse or rat insulin standards were used. Glucose was determined by the glucose oxidase method (Biochemica Test combination kit, C. F. Boehringer and Sons, Mannheim, W. Germany).
Calculations. Wet liver weights of ob/ob mice are about twice those of controls (controls: 1.29 g+0.03 SEM; ob/ob: 2.71 g±0.07; n = 13). Due to this, flow rates were adjusted to be twice as great in perfused livers of ob/ob mice as in those of controls (controls: 1.5 ml/min; ob/ob mice: 3.0 ml/min). Such a procedure is validated (Table I) by the finding that hepatic extraction of insulin was not affected by doubling the flow rate. For each experiment, calculations were thus made with individually measured flow rates, wet 'Abbreviation used in this paper: AIS, anti-insulin serum.
liver weights, and insulin concentrations present in the perfusate entering (cItn) and leaving (cI.ut) the liver, i.e.: c It. X flow rate/liver weight = IL. (ng/g/min); c Iout X flow rate/liver weight = Iut (ng/g/min).
Expression of results per gram of wet liver weight is justified, as the protein concentration of livers was found to be the same in both lean and ob/ob mice (controls 147.3 +7.8 mg/g liver; ob/ob 138.5±5.7; n = 4). Others have previously reported that protein and DNA concentrations were similar in livers of both lean and ob/ob mice (18) . It is assumed in the present experiments that the lipid concentration of livers (controls, 15+2 mg triglyceride/g liver; ob/ob, up to 151±12; n = 12) is not implicated in the removal process, since the latter represents a complex phenomenon including binding to receptors, degradation, and uptake, processes likely to involve protein components and not inert membrane-free intracellular triglyceride droplets. These experiments, however, have to be read with such an assumption in mind.
The difference i.n-Iout, measured as described above, represents the absolute removal of insulin. As shown by Fig. 1, after infusion Livers of 8-wk-old lean and ob/ob mice were perfused for 45 min with a nonrecirculating medium, as described in Fig. 1 . After a 15-min preperfusion without hormone, pork insulin was infused at a constant rate into the portal vein to obtain the concen- The flow rates were adjusted to 1.5 ml/min for livers of lean mice and 3 ml/min for livers of ob/ob mice. After a 15-min preperfusion without hormone, pork insulin was infused (hatched bars) at constant rates into the portal vein to obtain concentrations of 2.3 ng/g/min (left panel) and 20 ng/g/min (right panel), respectively. Insulin was determined in the perfusate entering the liver and, at various time intervals, in the perfusate leaving it after one passage. 
RESULTS
Effect of the concentration of infused insulin upon its removal by perfused livers. As can be seen in Table II , the absolute amount of insulin removed after one passage through the liver increased with increasing concentrations of the hormone infused into the portal vein. This was true for livers of both lean and ob/ob mice. However, at each insulin concentration, the removal of the hormone by livers of ob/ob mice was always significantly less than that of controls. As a consequence, and as illustrated by Fig. 2 , the percentage of the insulin removed by the liver was, at all insulin concentrations tested, considerably lower in livers of ob/ob than in livers of control mice. It has been shown ( Table I ) that insulin removal was not affected by flow rates. To substantiate further that the observed differences of insulin removal between livers of lean and ob/ob mice were indeed a real phenomenon, the following experiment was carried out. At perfusion time, livers of ob/ob mice were ligated to exclude from circulation and to remove surgically half of their mass. Under these condi- Livers from 8-wk-old lean and ob/ob mice were perfused as described in Fig. 1 ob/ob mice were injected intraperitoneally with streptozotocin (200 mg/kg body weight) and the experiment were carried out 11 days after the treatment. Plasma glucose and insulin levels were measured immediately before experiments. Livers were perfused for 60 min as described in Fig. 1 and Table I . Insulin removal was determined at the steady state as detailed in Methods and expressed as percent of insulin infused into the portal vein. Liver weights were: untreated mice, 2.91 gi0.13; streptozotocintreated mice, 2.62 g±0.14. Flow rate was 3 ml/min in both groups. Values are the means of four experiments ±SEM. * P < 0.05; t P < 0.0005. Livers from 8-wk-old fed, 2-or 7-days-fasted ob/ob mice were perfused as described in Fig. 1 (Table VII) .
In contrast to what was observed in ob/ob mice, when circulating insulin levels of lean mice were neutralized by AIS administration in vivo, no change in insulin removal by subsequently perfused livers was observed, as shown in Table VIII . This lack of change was not due to ineffective AIS, since plasma glucose concentrations rose (Table VIII) as did those of free fatty acids (untreated lean mice, 0.6+-0.1 mM; AIS-treated lean mice, 1.3±0.2 mM; n = 6).
It was thought unlikely that hepatic insulin removal could be influenced by the blood sugar prevailing before perfusion, since the removal process was found to be increased either by fasting (low blood sugar) or AIS administration (high blood sugar) (Tables IV-VII) . Actually, when 200 mg/100 ml glucose was directly added to the perfusion medium, hepatic insulin removal was not influenced in perfused livers from either fed or fasted lean mice (Table IX) . Such results are in keeping with similar observations made with an in vivo technique (19) . DISCUSSION Since the insulin produced by the f-cells of the pancreas must pass through the liver before its entry into the peripheral blood, the hepatic removal of the hormone may play a role in determining the final peripheral insulin concentration. Previous studies (10, 11) have indeed indicated that an inverse correlation appears to exist between the insulin concentration reaching the portal vein and the proportion of insulin removal by the liver. The present experiments have considerably substantiated the existence of such a correlation between plasma insulin concentration and hepatic insulin removal, and have extended it to livers of both lean and obese-hyperglycemic (ob/ob) mice. This study indicates that in livers of both lean and obese-hyperglycemic mice, the removal of insulin increases as the concentration of the hormone in the portal vein increases, until the process eventually becomes saturated (Table II) , as previously suggested for perfused livers of normal rats (9) . Considerably lower insulin concentrations were required to reach saturation in livers from ob/ob than from normal mice (Table II) . The limited capacity of the removal process may be best illustrated by the finding that the percentage of insulin removed actually decreased when increasing concentrations of the hormone reached the liver (Fig. 2) . Moreover, the removal of insulin by livers of ob/ob mice was considerably less efficient than that seen in livers of lean mice, for all insulin concentrations tested (Fig. 2) .
On the basis of such experiments, it is concluded that the efficiency of insulin removal by the liver is influ- Fig. 1 Livers from fed and 12-14-hr-fasted, 8-wk-old lean mice were perfused as described in Fig. 1 (Table IV) , by fasting (Table V) , or by anti-insulin treatment ( (Table IV-VII) , and is not altered by addition of glucose to the perfusion medium (Table IX) .
The nature of hepatic insulin removal is ill-defined. It may represent intermingled processes such as specific insulin-receptor interaction, actual uptake or trapping of the hormone at some unspecific site(s), or destruction or alteration of the hormone so that it lost its immunoreactivity. It is of note that changes in insulin removal and their relationship to hyperinsulinemia are qualitatively similar to those observed in the binding of insulin to isolated cells or membranes. Thus, it has been reported that insulin binding to various membrane types obtained from ob/ob mice was much lower than that of controls (21) (22) (23) , and that it was restored towards normal by fasting as well as by streptozotocin treatment (24) . In a similar fashion, exposure of isolated cultured human lymphocytes to insulin for 5-16 h produced a decrease in their insulin receptor concentrations, although acute exposure to the hormone (i.e. up to 2 h) was without effect (25) . The insulin removal reported in the present study, as well as the differences noted between livers of lean and ob/ob mice, may thus reflect changes in insulin receptors, alone or combination with other processes of insulin handling. Although it has been suggested that the degradation of labeled insulin by liver plasma membranes of ob/ob mice is somewhat less than that of controls, it has been emphasized that such differences in degradation are small compared to the observed differences in binding (26) .
Hyperinsulinemia of the ob/ob mice appears to occur early in the development of the syndrome (20) , and to be at the origin of several metabolic anomalies (13, 14) . Although it is very unlikely that the liver could play any primary role in hyperinsulinism, it is of interest to observe from these experiments that it does not adapt to hyperinsulinemia usefully but undergoes changes only likely to make hyperinsulinemia worse. Thus, the anomaly of insulin removal observed in livers of ob/ob mice could be yet another factor in the vicious metabolic cycles that eventually result in obesity and insulin resistance as previously reported (13, 14) . It is conceivable that such alterations might occur in humans, and thus be important in the pathophysiology of obesity, linked or unlinked to diabetes.
